Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2010 1
2015 1
2016 1
2017 4
2018 4
2019 6
2020 3
2021 10
2022 5
2023 4
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Caustic Ingestion: A Risk-Based Algorithm.
Tosca J, Sánchez A, Sanahuja A, Villagrasa R, Poyatos P, Mas P, Pascual I, Lluch P, Herreros B, Peña A, Sánchiz V, Mínguez M. Tosca J, et al. Am J Gastroenterol. 2022 Oct 1;117(10):1593-1604. doi: 10.14309/ajg.0000000000001953. Epub 2022 Aug 18. Am J Gastroenterol. 2022. PMID: 36194047
Pathogenesis of Crohn's disease: Bug or no bug.
Bosca-Watts MM, Tosca J, Anton R, Mora M, Minguez M, Mora F. Bosca-Watts MM, et al. Among authors: tosca j. World J Gastrointest Pathophysiol. 2015 Feb 15;6(1):1-12. doi: 10.4291/wjgp.v6.i1.1. World J Gastrointest Pathophysiol. 2015. PMID: 25685606 Free PMC article. Review.
Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor.
Ballester MP, Abril C, Merino V, Alós M, Segarra G, Tosca J, Montón C, Casasus N, Lluch P. Ballester MP, et al. Among authors: tosca j. Cancer Diagn Progn. 2024 Sep 1;4(5):623-630. doi: 10.21873/cdp.10373. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238615 Free PMC article.
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCU.
Aguas M, Del Hoyo J, Vicente R, Barreiro-de Acosta M, Melcarne L, Hernandez-Camba A, Madero L, Arroyo MT, Sicilia B, Chaparro M, Martin-Arranz MD, Pajares R, Mesonero F, Mañosa M, Martinez P, Chacón S, Tosca J, Marín S, Sanroman L, Calvo M, Monfort D, Saiz E, Zabana Y, Guerra I, Varela P, Baydal V, Faubel R, Corsino P, Porto-Silva S, Brunet E, González M, Gutiérrez A, Nos P. Aguas M, et al. Among authors: tosca j. J Med Internet Res. 2024 Nov 18;26:e60966. doi: 10.2196/60966. J Med Internet Res. 2024. PMID: 39189160 Free PMC article. Clinical Trial.
Clinical evaluation of drug-induced hepatitis.
Martí L, Del Olmo JA, Tosca J, Ornia E, García-Torres ML, Serra MA, Rodríguez F, Lluch P, Escudero A, Rodrigo JM. Martí L, et al. Among authors: tosca j. Rev Esp Enferm Dig. 2005 Apr;97(4):258-65. doi: 10.4321/s1130-01082005000400006. Rev Esp Enferm Dig. 2005. PMID: 15982181 Free article. English, Spanish.
HLA-DQ: Celiac disease vs inflammatory bowel disease.
Bosca-Watts MM, Minguez M, Planelles D, Navarro S, Rodriguez A, Santiago J, Tosca J, Mora F. Bosca-Watts MM, et al. Among authors: tosca j. World J Gastroenterol. 2018 Jan 7;24(1):96-103. doi: 10.3748/wjg.v24.i1.96. World J Gastroenterol. 2018. PMID: 29358886 Free PMC article.
Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy.
Ballester MP, Gallego JJ, Fiorillo A, Casanova-Ferrer F, Giménez-Garzó C, Escudero-García D, Tosca J, Ríos MP, Montón C, Durbán L, Ballester J, Benlloch S, Urios A, San-Miguel T, Kosenko E, Serra MÁ, Felipo V, Montoliu C. Ballester MP, et al. Among authors: tosca j. Sci Rep. 2022 Feb 14;12(1):2463. doi: 10.1038/s41598-022-06416-z. Sci Rep. 2022. PMID: 35165326 Free PMC article.
42 results